Three Days Into Trial, Cordis Hacks At Boston's Claims

Law360, New York (October 11, 2007, 12:00 AM EDT) -- In another bid for damage control in the stent suit Boston Scientific Corp. filed against it five years ago, Johnson & Johnson subsidiary Cordis Corp. has asked for judgment as a matter of law on the suit's claims of willful infringement of three patents.

“Litigants that make willful infringement claims have to prove them by clear and convincing evidence. Boston Scientific has failed to do so,” said Cordis in one of the two motions it filed on Thursday in the U.S. District Court for the Northern...
To view the full article, register now.